Kisqali User Reviews & Ratings (Page 2)
Kisqali has an average rating of 8.6 out of 10 from a total of 26 reviews on Drugs.com. 84% of reviewers reported a positive experience, while 4% reported a negative experience.
Reviews for Kisqali
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Kisqali (ribociclib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
For Breast Cancer, Metastatic "Very few side effects. Have been able to continue golf, pickleball, bridge, and a nice social life. 600 mg per day for 3 weeks, then one week off."